203 related articles for article (PubMed ID: 25181566)
21. The impact of hospice care on survival and cost saving among patients with liver cancer: a national longitudinal population-based study in Taiwan.
Chiang JK; Kao YH
Support Care Cancer; 2015 Apr; 23(4):1049-55. PubMed ID: 25281229
[TBL] [Abstract][Full Text] [Related]
22. Changes in Medicare costs with the growth of hospice care in nursing homes.
Gozalo P; Plotzke M; Mor V; Miller SC; Teno JM
N Engl J Med; 2015 May; 372(19):1823-31. PubMed ID: 25946281
[TBL] [Abstract][Full Text] [Related]
23. Hospice care in a commercial preferred provider organization population in Tennessee.
Coulter SL; Melvin T; Carden JP; Mathis RS
Am J Hosp Palliat Care; 2015 Mar; 32(2):168-72. PubMed ID: 24249830
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.
Bao Y; Maciejewski RC; Garrido MM; Shah MA; Maciejewski PK; Prigerson HG
J Pain Symptom Manage; 2018 Apr; 55(4):1113-1121.e3. PubMed ID: 29241809
[TBL] [Abstract][Full Text] [Related]
25. Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers.
Karve SJ; Price GL; Davis KL; Pohl GM; Smyth EN; Bowman L
BMC Health Serv Res; 2014 Nov; 14():555. PubMed ID: 25392276
[TBL] [Abstract][Full Text] [Related]
26. Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.
Fletcher SA; Cronin AM; Zeidan AM; Odejide OO; Gore SD; Davidoff AJ; Steensma DP; Abel GA
Cancer; 2016 Apr; 122(8):1209-15. PubMed ID: 26914833
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of hospice care.
Robinson BE; Pham H
Clin Geriatr Med; 1996 May; 12(2):417-28. PubMed ID: 8799358
[TBL] [Abstract][Full Text] [Related]
28. Differences in medical costs for end-of-life patients receiving traditional care and those receiving hospice care: A retrospective study.
Huang YT; Wang YW; Chi CW; Hu WY; Lin R; Shiao CC; Tang WR
PLoS One; 2020; 15(2):e0229176. PubMed ID: 32078660
[TBL] [Abstract][Full Text] [Related]
29. Longer Periods Of Hospice Service Associated With Lower End-Of-Life Spending In Regions With High Expenditures.
Wang S; Hsu SH; Huang S; Soulos PR; Gross CP
Health Aff (Millwood); 2017 Feb; 36(2):328-336. PubMed ID: 28167723
[TBL] [Abstract][Full Text] [Related]
30. Medicare cost in matched hospice and non-hospice cohorts.
Pyenson B; Connor S; Fitch K; Kinzbrunner B
J Pain Symptom Manage; 2004 Sep; 28(3):200-10. PubMed ID: 15336332
[TBL] [Abstract][Full Text] [Related]
31. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study).
Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M
Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965
[TBL] [Abstract][Full Text] [Related]
32. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
Kwan SW; Mortell KE; Hippe DS; Brunner MC
J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
[TBL] [Abstract][Full Text] [Related]
33. The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs.
Reyes C; DaCosta Byfield S; Linke R; Satram-Hoang S; Teitelbaum AH
Melanoma Res; 2013 Apr; 23(2):159-66. PubMed ID: 23370422
[TBL] [Abstract][Full Text] [Related]
34. The end of life costs for Medicare patients with advanced ovarian cancer.
Urban RR; He H; Alfonso R; Hardesty MM; Goff BA
Gynecol Oncol; 2018 Feb; 148(2):336-341. PubMed ID: 29208368
[TBL] [Abstract][Full Text] [Related]
35. Feasibility and economic impact of dedicated hospice inpatient units for terminally ill ICU patients.
Binney ZO; Quest TE; Feingold PL; Buchman T; Majesko AA
Crit Care Med; 2014 May; 42(5):1074-80. PubMed ID: 24351372
[TBL] [Abstract][Full Text] [Related]
36. Assessing the value of hospice care: is documentation of cost savings necessary.
Biskupiak J; Korner E
J Pain Palliat Care Pharmacother; 2005; 19(4):61-5. PubMed ID: 16431834
[TBL] [Abstract][Full Text] [Related]
37. "The high cost of dying" revisited.
Scitovsky AA
Milbank Q; 1994; 72(4):561-91. PubMed ID: 7997219
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Hemodialysis on Terminal Cancer Patients in Hospices: A Nationwide Retrospective Study in Taiwan.
Kang SC; Lin CC; Chen YC; Wang WS
J Palliat Med; 2019 Feb; 22(2):188-192. PubMed ID: 30601079
[TBL] [Abstract][Full Text] [Related]
39. Aggressive end-of-life care significantly influenced propensity for hospice enrollment within the last three days of life for Taiwanese cancer decedents.
Tang ST; Huang EW; Liu TW; Wang HM; Rau KM; Chen JS
J Pain Symptom Manage; 2011 Jan; 41(1):68-78. PubMed ID: 20828982
[TBL] [Abstract][Full Text] [Related]
40. An Educational Intervention to Decrease Drug Costs Related to Terminal Secretions in a Hospice Organization.
Brock C; Cooper S; Herndon CM
J Pain Palliat Care Pharmacother; 2017 Mar; 31(1):66-70. PubMed ID: 28287360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
